Cite
HARVARD Citation
Parasrampuria, D. et al. (2015). Response of authors to Ganju and Dias' comments on 'Inclusion of Placebos and Blinding for Ascending Dose First‐in‐Human Studies and Other Underpowered Phase 1 Studies Has Not Been Justified and on Balance is Not Useful' by D. A. Parasrampuria and L. Z. Benet. Basic & clinical pharmacology & toxicology. 117 (6), p. 367. [Online].